-
1
-
-
79952091223
-
Common nail changes and disorders in older people: Diagnosis and management
-
Abdullah L, Abbas O. Common nail changes and disorders in older people: Diagnosis and management. Can Fam Physician. 2011;57:173-181
-
(2011)
Can Fam Physician
, vol.57
, pp. 173-181
-
-
Abdullah, L.1
Abbas, O.2
-
2
-
-
34548187423
-
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: A meta-analysis
-
Chang CH, Young-Xu Y, Kurth T, Orav JE, Chan AK. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: A meta-analysis. Am J Med. 2007;120:791-798
-
(2007)
Am J Med
, vol.120
, pp. 791-798
-
-
Chang, C.H.1
Young-Xu, Y.2
Kurth, T.3
Orav, J.E.4
Chan, A.K.5
-
3
-
-
0031748868
-
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail
-
Scher RK, Breneman D, Rich P, et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998;38 (6, pt 2):S77-S86
-
(1998)
J Am Acad Dermatol
, vol.38
, Issue.6
, pp. S77-S86
-
-
Scher, R.K.1
Breneman, D.2
Rich, P.3
-
4
-
-
85022324653
-
-
Sporanox (itraconazole) [package insert]. Raritan, NJ: PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
-
Sporanox (itraconazole) [package insert]. Raritan, NJ: PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2011
-
(2011)
-
-
-
5
-
-
0033577556
-
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis
-
Evans EGV, Sigurgeirsson B for the LION Study Group. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. BMJ. 1999;318:1031-1035
-
(1999)
BMJ
, vol.318
, pp. 1031-1035
-
-
Evans, E.G.V.1
Sigurgeirsson, B.2
-
6
-
-
0035795995
-
Congestive heart failure associated with itraconazole
-
Ahmad SR, Singer SJ, Leissa BG. Congestive heart failure associated with itraconazole. Lancet. 2001;357:1766-1767
-
(2001)
Lancet
, vol.357
, pp. 1766-1767
-
-
Ahmad, S.R.1
Singer, S.J.2
Leissa, B.G.3
-
7
-
-
85022343834
-
-
Lamisil (terbinafine) [package insert]. East Hanover, NJ: Novartis Pharmaceuticals
-
Lamisil (terbinafine) [package insert]. East Hanover, NJ: Novartis Pharmaceuticals; 2012
-
(2012)
-
-
-
8
-
-
0030666538
-
Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial
-
Drake LA, Shear NH, Arlette JP, et al. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. J Am Acad Dermatol. 1997;37(5, pt1):740-745
-
(1997)
J Am Acad Dermatol
, vol.37
, Issue.5
, pp. 740-745
-
-
Drake, L.A.1
Shear, N.H.2
Arlette, J.P.3
-
9
-
-
0031595796
-
Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up
-
Tosti A, Piraccini BM, Stinchi C, Colombo MD. Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up. Dermatology. 1998;197:162-166
-
(1998)
Dermatology
, vol.197
, pp. 162-166
-
-
Tosti, A.1
Piraccini, B.M.2
Stinchi, C.3
Colombo, M.D.4
-
10
-
-
85022326182
-
-
Penlac (ciclopirox 8%) [package insert]. Bridgewater, NJ: Dermik Laboratories
-
Penlac (ciclopirox 8%) [package insert]. Bridgewater, NJ: Dermik Laboratories; 2006
-
(2006)
-
-
-
11
-
-
84884211501
-
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies
-
Elewski BE, Rich P, Pollak R, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68:600-608
-
(2013)
J Am Acad Dermatol
, vol.68
, pp. 600-608
-
-
Elewski, B.E.1
Rich, P.2
Pollak, R.3
-
12
-
-
85022323738
-
-
Accessed March 24, 2013
-
Tavaborole (AN2690). Available at: http://www.anacor.com/an2690.php. Accessed March 24, 2013
-
-
-
-
13
-
-
52949124801
-
The effects of laser irradiation on Trichophyton rubrum growth
-
Vural E, Winfield HL, Shingleton AW, Horn TD, Shafirstein G. The effects of laser irradiation on Trichophyton rubrum growth. Lasers Med Sci. 2008;23:349-353
-
(2008)
Lasers Med Sci
, vol.23
, pp. 349-353
-
-
Vural, E.1
Winfield, H.L.2
Shingleton, A.W.3
Horn, T.D.4
Shafirstein, G.5
-
14
-
-
57049140007
-
Enhancing the nail permeability of topically applied drugs
-
Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv. 2008;5:1267-1282
-
(2008)
Expert Opin Drug Deliv
, vol.5
, pp. 1267-1282
-
-
Murdan, S.1
-
15
-
-
0026906939
-
Noninvasive CO2 laser fenestration improves treatment of onychomycosis
-
Borovoy M, Tracy M. Noninvasive CO2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon. 1992;10:123-124
-
(1992)
Clin Laser Mon
, vol.10
, pp. 123-124
-
-
Borovoy, M.1
Tracy, M.2
-
16
-
-
53349098837
-
Photodynamic therapy of onychomycosis caused by Trichophyton rubrum
-
Piraccini BM, Rech G, Tosti A. Photodynamic therapy of onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 2008;59(5 suppl):S75-S76
-
(2008)
J Am Acad Dermatol
, vol.59
, Issue.5
, pp. S75-S76
-
-
Piraccini, B.M.1
Rech, G.2
Tosti, A.3
-
17
-
-
38549172228
-
Successful treatment of toenail onychomycosis with photodynamic therapy
-
Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. 2008;144:19-21
-
(2008)
Arch Dermatol
, vol.144
, pp. 19-21
-
-
Watanabe, D.1
Kawamura, C.2
Masuda, Y.3
Akita, Y.4
Tamada, Y.5
Matsumoto, Y.6
-
18
-
-
14844312114
-
Bioadhesive patchbased delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis
-
Donnelly RF, McCarron PA, Lightowler JM, Woolfson AD. Bioadhesive patchbased delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release. 2005;103:381-392
-
(2005)
J Control Release
, vol.103
, pp. 381-392
-
-
Donnelly, R.F.1
McCarron, P.A.2
Lightowler, J.M.3
Woolfson, A.D.4
-
19
-
-
80051711577
-
Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy
-
Gilaberte Y, Aspiroz C, Martes MP, Alcalde V, Espinel-Ingroff A, Rezusta A. Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol. 2011;65:669-671
-
(2011)
J Am Acad Dermatol
, vol.65
, pp. 669-671
-
-
Gilaberte, Y.1
Aspiroz, C.2
Martes, M.P.3
Alcalde, V.4
Espinel-Ingroff, A.5
Rezusta, A.6
-
20
-
-
85022343052
-
Onychomycosis therapy: Past, present, and future
-
Gupta A, Brintnell W. Onychomycosis therapy: Past, present, and future. J Am Acad Dermatol. 2012;66(4 suppl 1):AB120
-
(2012)
J Am Acad Dermatol
, vol.66
, Issue.4
-
-
Gupta, A.1
Brintnell, W.2
-
21
-
-
76249111790
-
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents
-
Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62:411-414
-
(2010)
J Am Acad Dermatol
, vol.62
, pp. 411-414
-
-
Piraccini, B.M.1
Sisti, A.2
Tosti, A.3
-
22
-
-
84973336613
-
Examination of cure and relapse of dermatophyte toenail onychomycosis during long-term follow-up after oral therapy
-
Gupta A, Cooper E. Examination of cure and relapse of dermatophyte toenail onychomycosis during long-term follow-up after oral therapy. J Am Acad Dermatol. 2012;66(4 suppl 1):AB119
-
(2012)
J Am Acad Dermatol
, vol.66
, Issue.4
-
-
Gupta, A.1
Cooper, E.2
-
23
-
-
84891604704
-
Promoting and maintaining or restoring healthy nails: Practical recommendations for clinicians and patients
-
Pariser D, Elewski B, Scher RK, Rich P. Promoting and maintaining or restoring healthy nails: Practical recommendations for clinicians and patients. Semin Cutan Med Surg. 2013;33:19-20
-
(2013)
Semin Cutan Med Surg
, vol.33
, pp. 19-20
-
-
Pariser, D.1
Elewski, B.2
Scher, R.K.3
Rich, P.4
|